Brief: Vicore Says C21 Can Become Important Complement To Covid-19 Vaccines

Vicore Pharma Holding AB

21/12/2020 07:04

Dec 21 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * POSITIVE RESULTS SHOW THAT C21 CAN BECOME AN IMPORTANT
COMPLEMENT TO COVID-19 VACCINES
    * REPORTS AN EXPANDED DATA ANALYSIS TO FOLLOW UP ENCOURAGING
TOP
LINE DATA FROM ATTRACT STUDY REPORTED ON DECEMBER 8, 2020.

Source text for Eikon:  ID:nWkr8tnlk6 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))